| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |